Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

Similar articles for PubMed (Select 22103497)

1.

Is inflammation the cause of pre-eclampsia?

Ramma W, Ahmed A.

Biochem Soc Trans. 2011 Dec;39(6):1619-27. doi: 10.1042/BST20110672. Review.

2.

Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.

Molvarec A, Szarka A, Walentin S, Szucs E, Nagy B, Rigó J Jr.

Hypertens Res. 2010 Sep;33(9):892-8. doi: 10.1038/hr.2010.92. Epub 2010 Jun 10.

PMID:
20535121
3.

Inflammation and pre-eclampsia.

Borzychowski AM, Sargent IL, Redman CW.

Semin Fetal Neonatal Med. 2006 Oct;11(5):309-16. Epub 2006 Jul 7. Review.

PMID:
16828580
4.

Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.

Verlohren S, Stepan H, Dechend R.

Clin Sci (Lond). 2012 Jan;122(2):43-52. doi: 10.1042/CS20110097. Review.

PMID:
21929511
5.

Contribution of angiogenic factors in a rat model of pre-eclampsia.

Agunanne EE, Uddin MN, Horvat D, Puschett JB.

Am J Nephrol. 2010;32(4):332-9. doi: 10.1159/000319463. Epub 2010 Aug 19.

PMID:
20720407
6.

Circulating levels of the anti-angiogenic thrombospondin 2 are elevated in pre-eclampsia.

Stenczer B, Molvarec A, Veresh Z, Gullai N, Nagy GR, Walentin S, Szijártó J, Rigó J Jr.

Acta Obstet Gynecol Scand. 2011 Nov;90(11):1291-5. doi: 10.1111/j.1600-0412.2011.01220.x. Epub 2011 Jul 28.

PMID:
21682699
7.

Placental ischaemia is a consequence rather than a cause of pre-eclampsia.

Ayuk PT, Matijevic R.

Med Hypotheses. 2006;67(4):792-5. Epub 2006 Jun 9.

PMID:
16762513
8.

Circulating angiogenic factors in pregnancies complicated by pre-eclampsia.

Varughese B, Bhatla N, Kumar R, Dwivedi SN, Dhingra R.

Natl Med J India. 2010 Mar-Apr;23(2):77-81.

PMID:
20925202
9.

Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.

Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, Koulisis N, Khankin EV, Burke SD, Tudorache I, Bauersachs J, del Monte F, Hilfiker-Kleiner D, Karumanchi SA, Arany Z.

Nature. 2012 May 9;485(7398):333-8. doi: 10.1038/nature11040.

10.

Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia.

Suwaki N, Masuyama H, Nakatsukasa H, Masumoto A, Sumida Y, Takamoto N, Hiramatrsu Y.

Am J Obstet Gynecol. 2006 Dec;195(6):1687-92. Epub 2006 Jun 12.

PMID:
16769024
11.

Pre-eclampsia: connecting angiogenic and metabolic pathways.

Shenoy V, Kanasaki K, Kalluri R.

Trends Endocrinol Metab. 2010 Sep;21(9):529-36. doi: 10.1016/j.tem.2010.05.002. Epub 2010 Jun 18. Review.

PMID:
20646932
12.

Placental stress and pre-eclampsia: a revised view.

Redman CW, Sargent IL.

Placenta. 2009 Mar;30 Suppl A:S38-42. doi: 10.1016/j.placenta.2008.11.021. Epub 2009 Jan 12.

PMID:
19138798
13.

The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.

Buhimschi CS, Baumbusch MA, Dulay AT, Lee S, Wehrum M, Zhao G, Bahtiyar MO, Pettker CM, Ali UA, Funai EF, Buhimschi IA.

BJOG. 2010 Feb;117(3):321-30. doi: 10.1111/j.1471-0528.2009.02434.x. Epub 2009 Nov 26.

PMID:
19943826
14.

Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.

Masuyama H, Segawa T, Sumida Y, Masumoto A, Inoue S, Akahori Y, Hiramatsu Y.

BJOG. 2010 Feb;117(3):314-20. doi: 10.1111/j.1471-0528.2009.02453.x. Epub 2009 Dec 10.

PMID:
20015306
15.

Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia.

Reddy A, Suri S, Sargent IL, Redman CW, Muttukrishna S.

PLoS One. 2009;4(2):e4453. doi: 10.1371/journal.pone.0004453. Epub 2009 Feb 11.

16.

Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction.

Schlembach D, Wallner W, Sengenberger R, Stiegler E, Mörtl M, Beckmann MW, Lang U.

Ultrasound Obstet Gynecol. 2007 Apr;29(4):407-13.

17.

Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.

Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.

J Hypertens. 2012 Nov;30(11):2173-81. doi: 10.1097/HJH.0b013e328357c0c9.

PMID:
22902831
18.

Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.

Xu B, Thornton C, Tooher J, Ogle R, Lim S, Makris A, Hennessy A.

Clin Exp Pharmacol Physiol. 2009 Aug;36(8):839-42. doi: 10.1111/j.1440-1681.2009.05155.x. Epub 2009 Feb 10.

PMID:
19215236
19.

Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?

Ahmed A, Cudmore MJ.

Biochem Soc Trans. 2009 Dec;37(Pt 6):1237-42. doi: 10.1042/BST0371237.

PMID:
19909254
20.

Angiogenic factors and pre-eclampsia: an early marker is needed.

Stepan H.

Clin Sci (Lond). 2009 Feb;116(3):231-2. doi: 10.1042/CS20080598.

PMID:
19032146
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk